MeSH term
Frequency | Condition_Probility | Animals | 30 | 0.0 |
Blotting, Western | 4 | 0.0 |
Cell Line | 17 | 0.0 |
Dimerization | 4 | 0.0 |
Enzyme Inhibitors/pharmacology | 7 | 0.0 |
Genes, Reporter | 6 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Histone Deacetylases/antagonists & inhibitors/metabolism | 2 | 11.0 |
Humans | 53 | 0.0 |
Hydroxamic Acids/pharmacology | 6 | 3.0 |
Ligands | 3 | 0.0 |
Models, Genetic | 4 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Precipitin Tests | 8 | 0.0 |
Protein Binding | 22 | 0.0 |
Rats | 2 | 0.0 |
Receptors, Thyroid Hormone/*metabolism | 2 | 5.0 |
Recombinant Fusion Proteins/metabolism | 5 | 0.0 |
Signal Transduction | 2 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Transcription, Genetic | 12 | 0.0 |
Transfection | 11 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Cell Cycle Proteins/metabolism | 3 | 0.0 |
Cell Division | 3 | 0.0 |
Exons | 2 | 0.0 |
Histones/metabolism | 8 | 3.0 |
Mice | 17 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Amino Acid Sequence | 20 | 0.0 |
Hela Cells | 14 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Molecular Sequence Data | 22 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 35 | 0.0 |
Acetylation | 14 | 2.0 |
Histones/*metabolism | 3 | 2.0 |
Base Sequence | 8 | 0.0 |
*Trans-Activation (Genetics) | 3 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Cytoplasm/metabolism | 5 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Tissue Distribution | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Enzyme Activation | 3 | 0.0 |
Histone Deacetylases/genetics/*metabolism | 4 | 9.0 |
Repressor Proteins/genetics/*metabolism | 3 | 1.0 |
Active Transport, Cell Nucleus | 5 | 2.0 |
Cell Nucleus/enzymology | 2 | 2.0 |
Cytoplasm/enzymology | 2 | 2.0 |
Catalysis | 2 | 0.0 |
Histone Deacetylases/*metabolism | 7 | 6.0 |
COS Cells | 6 | 0.0 |
Zinc Fingers | 4 | 0.0 |
Acetyltransferases/metabolism | 2 | 2.0 |
DNA/metabolism | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
NF-kappa B/*metabolism | 4 | 0.0 |
Nuclear Proteins/metabolism | 7 | 0.0 |
Phosphorylation | 4 | 0.0 |
Protein Transport | 3 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Binding Sites | 3 | 0.0 |
Histone Deacetylases/metabolism | 4 | 4.0 |
Lysine/genetics/metabolism | 2 | 10.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 3 | 0.0 |
3T3 Cells | 3 | 0.0 |
*Cell Cycle Proteins | 2 | 0.0 |
Repressor Proteins/metabolism | 7 | 3.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
14-3-3 Proteins | 2 | 1.0 |
Models, Biological | 4 | 0.0 |
Sequence Alignment | 7 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Histone Deacetylases/chemistry/*metabolism | 2 | 28.0 |
Amino Acid Motifs | 2 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Histone Deacetylases/*chemistry/genetics/*metabolism | 2 | 40.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 2 | 1.0 |
Apoptosis | 3 | 0.0 |
Mutation | 5 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Gene Expression Regulation | 4 | 0.0 |
Cercopithecus aethiops | 3 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Histone Deacetylases/chemistry/genetics/*metabolism | 2 | 20.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Repressor Proteins/chemistry/genetics/*metabolism | 2 | 4.0 |
Organ Specificity | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
Histone Deacetylases/*chemistry/metabolism | 2 | 100.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 5 | 2 | 0.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
Histone Deacetylases/*genetics | 4 | 23.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Gene Dosage | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Gene Silencing | 3 | 0.0 |
Histones/chemistry/metabolism | 2 | 11.0 |
Hydroxamic Acids/*pharmacology | 3 | 6.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Histone Deacetylases/*antagonists & inhibitors | 2 | 4.0 |
Blotting, Northern | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
RNA Interference | 3 | 1.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Serine/chemistry | 2 | 1.0 |
Histone Deacetylases/*genetics/metabolism | 2 | 25.0 |
Female | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Histone Deacetylases/*antagonists & inhibitors/metabolism | 2 | 13.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
